Tag: 5 asa

Affecting as many as 1.25 million people in the United States, ulcerative colitis is a chronic inflammatory condition. A primary treatment for this condition is an anti-inflammatory drug, but what is mesalamine and how does it help manage the disease?

An estimated 2.39 million Americans have Inflammatory Bowel Disease (IBD), a condition often treated with sulfasalazine [1.7.4]. Understanding **how does Azulfidine work** involves looking at its journey through the body and its breakdown into two key components that reduce inflammation [1.2.1, 1.2.2].

Approximately 2.4% of an oral dose of olsalazine is absorbed into the bloodstream, with the vast majority of the medication reaching the colon where it is needed. This targeted delivery mechanism is key to understanding how olsalazine works as a specialized anti-inflammatory medication for managing ulcerative colitis.

Research suggests that up to 900,000 people in the United States have ulcerative colitis, a lifelong inflammatory bowel disease (IBD) [1.8.1]. For those managing this chronic condition, a key question arises: **can you stay on mesalamine long term** for effective management?